Aagami has a new client, new assignment for Market Landscape Research. Once completed, the client would appoint Aagami to support their partnerin...
Published : 11 Jun 2023
Read MoreAagami successfully completed BIO International Convention 2023 (June 5-8) in Boston with 45+ one-on-one meetings with decision makers in Biotech, Pha...
Published : 10 Jun 2023
Read MoreAagami has been appointed by a Pennsylvania Pharma to support their strategic partnering needs. Client is a Biopharma R&D focused company tha...
Published : 15 May 2023
Read MoreA Portland based Biotech has appointed Aagami to support their strategic investment and partnering needs. The CEO of client company has kno...
Published : 12 May 2023
Read MoreAn existing client from San Francisco has awarded a new assignment to Aagami for supporting their fund-raising needs again. The Client is a...
Published : 01 May 2023
Read MoreSuccess Story: Aagami secures funding for US client developing First-in-Class Non-Opioid Analgesic for Pain Relief We are pleased to announce tha...
Published : 22 Apr 2023
Read MoreAagami has been appointed as consultant by another Korean client which has developed world’s first digital monitoring and management solution for Th...
Published : 10 Apr 2023
Read MoreAagami has a new client. This time it is an Award-winning New York biotech specializing in molecular engineering, RNAi and CRISPR/Cas9 technologi...
Published : 07 Apr 2023
Read MoreAagami CEO, Dinesh Jain, is participating in the 2023 BIO International Convention which will be held in Boston (June 5-8, 2023). This Annual eve...
Published : 29 Mar 2023
Read MoreWe are glad to inform that Aagami CEO Dinesh Jain will be attending DCAT Week 2023 in person from MARCH 20 to 23 in New York City. If you or...
Published : 24 Feb 2023
Read More